SCHEMBL26048932

SCHEMBL26048932

CCCC[C@H](C)CSC(C)[C@@H](C)S

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
DNM1 Q05193 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28012587 0.73 EPHX1 (0.36)
SCHEMBL28111365 0.72 DNM1 (0.38) ALDH1A1TDP1DNM1
SCHEMBL8813653 0.69
SCHEMBL56652 0.68 LMNA (0.50) ALDH1A1TDP1DNM1
SCHEMBL23484289 0.67 TSHR (0.39)
SCHEMBL13974336 0.67 DNM1 (0.33) ALDH1A1TDP1DNM1
SCHEMBL18256105 0.66 ACE2 (0.43) ALDH1A1TDP1DNM1
SCHEMBL24831364 0.66 LMNA (0.43) ALDH1A1TDP1DNM1
SCHEMBL18286447 0.66 ACE2 (0.43) ALDH1A1TDP1DNM1
SCHEMBL31521551 0.66 LMNA (0.56) ALDH1A1TDP1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4223309-A1 COMBINATION THERAPY WITH CONTROLLED-RELEASE CNP AGONISTS Ascendis Pharma Growth Disorders A/S (DK) 2023-08-09 EP disclosed